Register for providers of injectable cosmetic treatments is misguided and not addressing substandard practice says BABTAC’s chairman
Posted By Journalist on September 27, 2010
The recent (IHAS) Independent Healthcare Advisory Services’ call for a voluntary register for cosmetic treatments such as botox and dermal fillers looks set to be a worrying public safety concern and drastically limit public choice.
The register’s objective hopes to provide public reassurance on the competency of practitioners who inject botox type toxins and fillers to soften facial lines and wrinkles. Strangely, the new radical move will automatically bar highly qualified aesthetic practitioners even though these professionals have a consistently low client dissatisfaction and claims rate.
The Chairman of the British Association for Beauty Therapy and Cosmetology (BABTAC) insists the newly proposed government backed register for providers of injectable cosmetic treatments is misguided and not addressing substandard practice. Angela Bartlett, Chairman for BABTAC (British Association for Beauty Therapy and Cosmetology) is gravely concerned that the IHAS guidelines will only confuse the public and cause these practices to go underground.
She states, “Guidelines should be all inclusive. Our industry has always welcomed protective legislation but putting cosmetic injectable treatments into purely medical hands as a ‘knee jerk reaction’ is not the answer. This scheme is symbolic of over-regulation for a minority situation. The legislation means that bizarrely, only doctors, dentists and nurses will be eligible. The medical practitioner will have no requirement to undertake any aesthetic training and the register is based on ‘merit of title’ rather than appropriate experience or qualifications. These people do not have any aesthetic training and we fear for business livelihoods in the beauty sector disappearing overnight just because of a short sighted attempt at extreme regulation.”
“The ideal solution we would welcome is to use an independent inspectorate to inspect all practitioners so they can carry out a full audit trail on prescribed botulinum toxin. The IHAS scheme has overlooked this completely and can only push the popularity of non-registered injectable therapists. This scenario is actually a frightening prospect in a marketplace where the customer wants pleasing aesthetic results.”
Source:cosmeticnewsportal.com
Comments
Leave a Reply